Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. Case and Commentary Mar 2022 Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors Nhi Tran, MD, MPH, Aminta Kouyate, and Monica U. Hahn, MD, MPH, MS Patients’ adherence to recommendations can unjustly influence their candidacy for a current intervention. AMA J Ethics. 2022;24(3):E181-187. doi: 10.1001/amajethics.2022.181. Medicine and Society Mar 2022 Narrative, Compassion, and Counter Stories Aleksandra E. Olszewski, MD, MA Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins. AMA J Ethics. 2022;24(3):E212-217. doi: 10.1001/amajethics.2022.212. Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226. Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
Case and Commentary Mar 2022 Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors Nhi Tran, MD, MPH, Aminta Kouyate, and Monica U. Hahn, MD, MPH, MS Patients’ adherence to recommendations can unjustly influence their candidacy for a current intervention. AMA J Ethics. 2022;24(3):E181-187. doi: 10.1001/amajethics.2022.181.
Medicine and Society Mar 2022 Narrative, Compassion, and Counter Stories Aleksandra E. Olszewski, MD, MA Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins. AMA J Ethics. 2022;24(3):E212-217. doi: 10.1001/amajethics.2022.212.
Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226.
Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.